Companies / Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc.
Nasdaq: INDVCIK 1625297NORTH CHESTERFIELD, VA
Financials · FY2025
Ownership
118.0M shares outstanding · as of Jul 28, 2026
Ownership
| Insiders | 0.79% | 933,774 |
| 10%+ / strategic | 20.49% | 24,177,717 |
| Institutions | 30.59% | 36,100,975 |
| Public float | 48.13% | 56,801,183 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 13
View all →| Insider | % of shares | Shares |
|---|---|---|
Preblick RyanChief Financial Officer | 0.27% | 320,751 |
Heidbreder ChristianChief Scientific Officer | 0.21% | 246,509 |
Ciaffoni JosephCEOChief Executive Officer · Director | 0.12% | 135,976 |
Burris Jeffrey WChief Legal Officer | 0.06% | 71,518 |
Barry Patrick AChief Commercial Officer | 0.03% | 31,380 |
Ninivaggi Daniel aDirector | 0.02% | 27,163 |
Anderson Woodrow DChief Accounting Officer | 0.02% | 24,638 |
Stejbach MarkDirector | 0.02% | 20,569 |
Wheadon David E.Director | 0.02% | 20,350 |
Kingsley Stuart ADirector | 0.01% | 12,100 |
Institutional holders 87
View all →| Holder | Value | % of shares |
|---|---|---|
| $767.65M | 15.85% | |
| $225.34M | 5.32% | |
| $204.82M | 4.23% | |
| $140.07M | 3.89% | |
| $138.06M | 3.84% | |
| $94.42M | 2.62% | |
| $89.19M | 2.48% | |
| $71.77M | 1.70% | |
| $70.81M | 1.97% | |
| $37.12M | 1.03% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Preblick Ryan Executive | Other | Common Stock | $2.80M | -88K -27.55% | 230,343 0.20% of shares | low |
| Mar 3, 2026 | Heidbreder Christian Executive | Other | Common Stock | $1.46M | -46K -15.67% | 246,509 0.21% of shares | low |
| Mar 3, 2026 | Burris Jeffrey W Executive | Other | Common Stock | $1.15M | -36K -33.50% | 71,518 0.06% of shares | low |
| Mar 3, 2026 | Anderson Woodrow D Executive | Other | Common Stock | $264.9K | -8K -27.93% | 21,374 0.02% of shares | low |
| Mar 14, 2026 | Preblick Ryan Executive | Other | Common Stock | $88.4K | -3K -0.88% | 320,751 0.27% of shares | low |
| Mar 3, 2026 | Anderson Woodrow D Executive | Other | Common Stock | $85.8K | -3K -9.82% | 24,638 0.02% of shares | low |
| Jan 5, 2026 | Wheadon David E. Director | Buy | Ordinary Shares | $62.7K | +2K +14.03% | 14,395 0.01% of shares | medium |
| Mar 6, 2026 | Kingsley Stuart A Director | Buy | Common Stock | $30.0K | +940 +20.25% | 5,582 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Fuller & Thaler Asset Management, Inc. | Passive13G | — |
| Millennium Management LLC | Passive13G | — |
| BlackRock, Inc. | Passive13G/A | — |
| The Goldman Sachs Group, Inc. | Passive13G/A | — |
| Madison Avenue International LP | Passive13G/A | — |
| Fuller & Thaler Asset Management, Inc. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| INDV | — | 45579U109 |